Vertical Integration Has Little Impact on Quality Measures
Increased hospital market concentration tied to reduced quality in patient satisfaction measures
Sacituzumab Govitecan Promising in Triple-Negative Breast Cancer
Response rate of 33.3 percent, median response duration of 7.7 months observed in 108 patients
Rivaroxaban Does Not Reduce VTE Incidence in High-Risk Cancer Patients
Primary end point occurred in lower percentage of patients in 180-day period; difference not significant
U.S. Agencies Probing Johnson & Johnson Over Asbestos in Talc
Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma
FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy
Proposed rule will help consumers better understand what the sunscreens they are buying can actually do
8 More U.S. Communities to Be Assessed for PFAS Toxin Exposure
Assessments will lay groundwork for future study of the health effects of perfluoroalkyl, polyfluoroalkyl
Glottic Carcinoma Can Be HPV-Related Disease in Young Adults
Cases of glottic carcinoma in patients aged 30 years or younger tested positive for high-risk HPV
Structural, Clinical Barriers Prevent Cancer Trial Participation
Trial unavailable at patients' institution 55.6 percent of the time; 21.5 percent of patients ineligible
Black-White Cancer Mortality Gap Decreasing in Some Age Groups
Cancer deaths rates decreasing faster for black men and women vs. white men and women in U.S.
Combo Regimens Effective for Tx of Metastatic Renal Cell Cancer
Two large trials show benefits for pembrolizumab-axitinib and avelumab-axitinib versus sunitinib
